Soligenix

Soligenix possesses specialized expertise in the advancement of rare and unmet medical necessities, encompassing preclinical, production, regulatory, and clinical proficiencies. As a mature biopharmaceutical firm, our commitment lies in the development and distribution of treatments for rare diseases with unaddressed medical requirements. Our range of Public Health initiatives, exclusively supported by government grants and agreements, is dedicated to infectious disease and biodefense applications, including our most advanced vaccination program for preventing ricin poisoning.